Overexpression of folate binding protein in ovarian cancers

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 193-198

  Toffoli, Giuseppe ^a   Cernigoi, Claudia ^a   Russo, Antonio ^a   Gallo, Angelo ^a   Bagnoli, Marina ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FOLATE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE PHASE; CYTOFLUOROMETRY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PLOIDY; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CARRIER PROTEINS; CYSTADENOCARCINOMA, SEROUS; DIPLOIDY; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; S PHASE;

EID: 0030910859     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F     Document Type: Article

References (27)

1. ANTONY, A.C., The biological chemistry of folate receptors. Blood, 79, 2807-2820 (1992).
2. BOTTERO, F., TOMASSETTI, A., CANEVARI, S., MIOTTI, S., MÉNARD, S. and COLNAGHI, M.I., Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo. Cancer Res., 53, 5791-5796 (1993).
3. CAMPBELL, I.G., JONES, T.A., FOULKES, W.D. and TROWSDALE, J., Folate-binding protein is a marker for ovarian cancer. Cancer Res., 51, 5329-5338 (1991).
4. CANNISTRA, S.A., Cancer of the ovary. N. Engl. J. Med., 329, 1550-1559 (1993).
5. CHUNG, K.N., SAIKAWA, Y., PAIK, T.H., DIXON, K.H., MULLIGAN, T., COWAN, K.H. and ELWOOD, P.C., Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J. clin. Invest., 91, 1289-1294 (1993).
6. CONEY, L.R., MEZZANZANICA, D., SANBORN, D., CASALINI, P., COLNAGHI, M.I. and ZURAWSKI, V.R., Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res., 54, 2448-2455 (1994).
7. DEUTSCH, J.C., ELWOOD, P.C., PORTILLO, R.M., MACEY, M.G. and KOLHOUSE, J.F., Role of the membrane-associated folate binding protein (folate receptor) in methotrexate transport by human KB cells. Arch. Biochem. Biophys., 274, 327-337 (1989).
8. ELWOOD, P.C., Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. biol. Chem., 264, 14893-14901 (1989).
9. GAUDRAY, P., SZEPETOWSKI, P., ESCOT, C., BIRNBAUM, D. and THEILLET, C., DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutation Res., 276, 317-328 (1992).
10. HENDERSON, G.B., Folate-binding proteins. Ann. Rev. Nutr., 10, 319-335 (1990).
11. INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS, Changes in definition of clinical staging for carcinoma of the cervix and ovary. Amer. J. Obstet. Gynecol., 56, 263-264 (1987).
12. KALLIONIEMI, O.P., PUNNONEN, R., MATTILA, J., LEHTINEN, M. and KOIVULA, T., Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer. Cancer, 61, 334-339 (1988).
13. KANE, M.A., ELWOOD, P.C., PORTILLO, R.M., ANTONY, A.C. and KOLHOUSE, J.F., The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells. J. biol. Chem., 261, 15625-15631 (1986).
14. KAYE, S.B., Ovarian cancer, from the laboratory to the clinic: challenges for the future. Ann. Oncol., 7, 9-13 (1996).
15. LACEY, S.W., SANDERS, J.M., ROTHBERG, K.G., ANDERSON, R.G. and KAMEN, B.A., Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. clin. Invest., 84, 715-720 (1989).
16. LOWE, S.W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E. and JACKS, T., p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810 (1994).
17. LUHRS, C.A., RASKIN, C.A., DURBIN, R., WU, B., SADASIVAN, E., MCALLISTER, W. and ROTHENBERG, S.P., Transfection of a glycosylated phosphatidyl-inositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium. J. clin. Invest., 90, 840-847 (1992).
18. MANTOVANI, L.T., MIOTTI, S., MÉNARD, S., CANEVARI, S., RASPAGLIESI, F., BOTTINI, C., BOTTERO, F. and COLNAGHI, M.I., Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv 18 and MOv 19. Europ. J. Cancer, 30A, 363-369 (1994).
19. MIOTTI, S., CANEVARI, S., MÉNARD, S., MEZZANZANICA, D., PORRO, G., PUPA, S.M., REGAZZONI, M., TAGLIABUE, E. and COLNAGHI, M.I., Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer, 39, 297-303 (1987).
20. ORR, R.B. and KAMEN, B.A., UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a mutant nonfunctional folate receptor. Cancer Res., 54, 3905-3911 (1994).
21. ORR, R.B., KREISLER, A.R. and KAMEN, B.A., Similarity of folate receptor expression in UMSCC38 cells to squamous cell carcinoma differentiation markers. J. nat. Cancer Inst., 87, 299-303 (1995).
22. RATNAM, M., MARQUARDT, H., DUHRING, J.L. and FREISHEIM, J.H., Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry, 28, 8249-8254 (1989).
23. REMVIKOS, Y., LAURENT PUIG, P., SALMON, R.J., FRELAT, G., DUTRILLAUX, B. and THOMAS, G., Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int. J. Cancer, 45, 450-456 (1990).
24. ROSS, J.F., CHAUDHURI, P.K. and RATNAM, M., Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer, 73, 2432-2443 (1994).
25. SEROV, S.F. and SOULLY, R.F. Histological typing of ovarian tumors. In: International histological classification of tumors. Geneva: World Health Organization (1973).
26. SHEN, F., ROSS, J.F., WANG, X. and RATNAM, M., Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry, 33, 1209-1215 (1994).
27. VEGGIAN, R., FASOLATO, S., MÉNARD, S., MINUCCI, D., PIZZETI, P., REGAZZONI, M., TAGLIABUE, E. and COLNAGHI, M.I., Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori, 75, 510-513 (1989).